Wave life sciences to present at the h.c. wainwright 23rd annual global investment conference

Cambridge, mass., sept. 07, 2021 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to give a pre-recorded presentation at the h.c. wainwright 23rd annual global investment conference, which will be made available for on-demand viewing on monday, september 13, 2021 at 7:00 a.m. et.
WVE Ratings Summary
WVE Quant Ranking